Get App
Last Updated : May 17, 2020 09:29 PM IST | Source:

Buy Cipla target of Rs 650: Sharekhan

Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 650 in its research report dated May 15, 2020.

Broker Research @moneycontrolcom
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Cipla

Cipla reported weak numbers for Q4FY2020 impacted by the operational challenges due to COVID-19 pandemic. While the topline was flat, Adj PAT dropped 52.7% yoy. Cipla’s move to merge three segments (prescription, trade generics and consumer health) in the Indian business are expected to yield synergies and would boost the performance of the India business. South Africa business is also expected to clock a healthy growth. US business is likely to gain traction backed by new products / fillings lined up. This would strengthen Cipla’s respiratory franchise in the US market.


We maintain our Buy recommendation on the stock with an unchanged PT of Rs. 650.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Get best insights into Options Trading. Join the webinar by Mr. Vishal B Malkan on May 28 only on Moneycontrol. Register Now!

First Published on May 17, 2020 09:29 pm
Follow us on